12:00 AM
 | 
May 06, 2013
 |  BC Week In Review  |  Company News  |  Deals

GNS Healthcare, Harvard Medical School deal

Harvard Medical School acquired a five-year license to GNS' Reverse Engineering and Forward Simulation (REFS) technology to characterize signaling and transcriptional events in biological systems,...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >